Functional proteomics to dissect tyrosine kinase signalling pathways in cancer
|Title:||Functional proteomics to dissect tyrosine kinase signalling pathways in cancer||Authors:||Kolch, Walter
|Permanent link:||http://hdl.handle.net/10197/5073||Date:||19-Aug-2010||Online since:||2013-11-29T10:11:43Z||Abstract:||Advances in the generation and interpretation of proteomics data have spurred a transition from focusing on protein identification to functional analysis. Here we review recent proteomics results that have elucidated new aspects of the roles and regulation of signal transduction pathways in cancer using the epidermal growth factor receptor (EGFR), ERK and breakpoint cluster region (BCR)–ABL1 networks as examples. The emerging theme is to understand cancer signalling as networks of multiprotein machines which process information in a highly dynamic environment that is shaped by changing protein interactions and post-translational modifications (PTMs). Cancerous genetic mutations derange these protein networks in complex ways that are tractable by proteomics.||Type of material:||Journal Article||Publisher:||Nature Publishing Group||Journal:||Nature Reviews Cancer||Volume:||10||Issue:||9||Start page:||618||End page:||629||Copyright (published version):||2010 Nature Publishing Group||Keywords:||Functional proteomics; signal transduction pathways; cancer; epidermal growth factor receptor (EGFR); ERK; breakpoint cluster region (BCR)–ABL1||DOI:||10.1038/nrc2900||Language:||en||Status of Item:||Peer reviewed|
|Appears in Collections:||SBI Research Collection|
Show full item record
Page view(s) 5038
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.